139 related articles for article (PubMed ID: 2127171)
1. Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.
Christenson JG; Chan KK; Cleeland R; Dix-Holzknecht B; Farrish HH; Patel IH; Specian A
Antimicrob Agents Chemother; 1990 Oct; 34(10):1895-900. PubMed ID: 2127171
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Beskid G; Siebelist J; McGarry CM; Cleeland R; Chan K; Keith DD
Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064
[TBL] [Abstract][Full Text] [Related]
3. Mode of action of the dual-action cephalosporin Ro 23-9424.
Georgopapadakou NH; Bertasso A; Chan KK; Chapman JS; Cleeland R; Cummings LM; Dix BA; Keith DD
Antimicrob Agents Chemother; 1989 Jul; 33(7):1067-71. PubMed ID: 2675755
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
Pace J; Bertasso A; Georgopapadakou NH
Antimicrob Agents Chemother; 1991 May; 35(5):910-5. PubMed ID: 1649574
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
Beskid G; Fallat V; Lipschitz ER; McGarry DH; Cleeland R; Chan K; Keith DD; Unowsky J
Antimicrob Agents Chemother; 1989 Jul; 33(7):1072-7. PubMed ID: 2782857
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime.
Jones RN; Barry AL; Thornsberry C
Antimicrob Agents Chemother; 1989 Jun; 33(6):944-50. PubMed ID: 2504106
[TBL] [Abstract][Full Text] [Related]
7. beta-Lactamase hydrolysis of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines.
Georgopapadakou NH; McCaffrey C
Antimicrob Agents Chemother; 1994 May; 38(5):959-62. PubMed ID: 8067776
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics.
Gu JW; Neu HC
Antimicrob Agents Chemother; 1990 Feb; 34(2):189-95. PubMed ID: 2327765
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of Ro 24-6778, a covalent bonding of desmethylfleroxacin and desacetylcefotaxime.
Jones RN
Diagn Microbiol Infect Dis; 1990; 13(3):253-9. PubMed ID: 2116952
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of Ro 23-9424, a dual-acting cephalosporin-quinolone antimicrobial agent.
Qadri SM; Ueno Y; Saldin H; Cunha BA
J Clin Pharmacol; 1993 Oct; 33(10):923-8. PubMed ID: 8227462
[TBL] [Abstract][Full Text] [Related]
11. Determination of a new antibacterial agent (Ro 23-9424) by multidimensional high-performance liquid chromatography with ultraviolet detection and direct plasma injection.
Szuna AJ; Blain RW
J Chromatogr; 1993 Oct; 620(2):211-6. PubMed ID: 8300788
[TBL] [Abstract][Full Text] [Related]
12. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial.
Qadri SM; Ueno Y; Ayub A
Chemotherapy; 1993; 39(6):386-9. PubMed ID: 8222864
[TBL] [Abstract][Full Text] [Related]
13. Low-level resistance to the cephalosporin 3'-quinolone ester Ro 23-9424 in Escherichia coli.
Chapman JS; Bertasso A; Cummings LM; Georgopapadakou NH
Antimicrob Agents Chemother; 1995 Feb; 39(2):564-6. PubMed ID: 7726536
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
Jones RN; Sanchez ML
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):61-8. PubMed ID: 8026159
[TBL] [Abstract][Full Text] [Related]
15. RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteria.
Pfaller MA; Barry AL; Fuchs PC
J Antimicrob Chemother; 1993 Jan; 31(1):81-8. PubMed ID: 8444677
[TBL] [Abstract][Full Text] [Related]
16. Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in rats.
Rubinstein E; Dautrey S; Farinoti R; St Julien L; Ramon J; Carbon C
Antimicrob Agents Chemother; 1995 Jan; 39(1):99-102. PubMed ID: 7695338
[TBL] [Abstract][Full Text] [Related]
17. Cephalosporin 3'-quinolone esters with a dual mode of action.
Albrecht HA; Beskid G; Chan KK; Christenson JG; Cleeland R; Deitcher KH; Georgopapadakou NH; Keith DD; Pruess DL; Sepinwall J
J Med Chem; 1990 Jan; 33(1):77-86. PubMed ID: 2153215
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.
Rolston KV; Nguyen HT; Ho DH; LeBlanc B; Bodey GP
Antimicrob Agents Chemother; 1992 Apr; 36(4):879-82. PubMed ID: 1503453
[TBL] [Abstract][Full Text] [Related]
19. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
Hummler H; Richter WF; Hendrickx AG
Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
[TBL] [Abstract][Full Text] [Related]
20. Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes.
Matera G; Berlinghieri MC; Foti F; Barreca GS; Focà A
J Antimicrob Chemother; 1996 Nov; 38(5):799-807. PubMed ID: 8961049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
